MedTrace Logo

To Assess the Safety and Effectiveness of Hyruan ONE Versus a Comparator for the Treatment of Knee Osteoarthritis in Europe

NCT04732793 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 284

Last updated 2022-03-16

No results posted yet for this study

Summary

To Assess the Safety and Effectiveness of Hyruan ONE versus a Comparator for the Treatment of Knee Osteoarthritis in Europe

Conditions

  • Osteoarthritis (OA) of the Knee

Interventions

DEVICE

Hyruan ONE®

For use as a symptomatic treatment of osteoarthritis (OA) of the knee

DEVICE

Durolane®

For use as a symptomatic treatment of osteoarthritis (OA) of the knee

Sponsors & Collaborators

  • LG Chem

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-03
Primary Completion
2021-06-11
Completion
2021-12-07

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04732793 on ClinicalTrials.gov